Related Experiment Videos

The microbiology of transmissible murine colonic hyperplasia

Laboratory Animal Science
|April 1, 1980
PubMed

Insights

Citrobacter freundii (4280) can cause colonic hyperplasia in mice. Even short-term presence of this bacterium stimulates significant mucosal hyperplasia, with longer exposure increasing the severity.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pathology

Background:

  • Citrobacter freundii (4280) is a bacterium that has been investigated for its role in gastrointestinal conditions.
  • Colonic hyperplasia is an increase in the number of cells in the colon lining, which can be a precursor to other issues.

Purpose of the Study:

  • To investigate the relationship between Citrobacter freundii (4280) and the development of colonic hyperplasia in a mouse model.
  • To determine the duration of infection and its correlation with hyperplasia.

Main Methods:

  • Experimental inoculation of mice with Citrobacter freundii (4280).
  • Quantitation of bacterial numbers in the descending colon at various time points.
  • Correlation of bacterial presence with histological and ultrastructural findings of mucosal hyperplasia.

Main Results:

  • Citrobacter freundii (4280) infection was transient, lasting approximately 2-3 weeks.
  • As little as 2 days of bacterial presence was sufficient to induce detectable mucosal hyperplasia.
  • Prolonged presence of the bacterium (up to 10 days) resulted in progressively greater hyperplasia.
  • Neomycin sulfate and tetracycline hydrochloride were effective in preventing and treating the infection.

Conclusions:

  • Citrobacter freundii (4280) can act as a stimulus for colonic mucosal hyperplasia in mice.
  • The duration of exposure to Citrobacter freundii (4280) directly correlates with the severity of hyperplasia.
  • Antibiotic treatment can prevent and clear Citrobacter freundii (4280) infections.

Related Concept Videos